ArticleMedicine2024

Complete pathologic response to neoadjuvant icotinib in stage IIIA EGFR-mutant lung adenosquamous carcinoma: A case report.

Zhongfu Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.